{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:55:49Z","timestamp":1793051749675,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Schwangerschaft und Schmerzen unterschiedlicher Herkunft sind eine ung\u00fcnstige Kombination, die alle BehandlerInnen vor besondere Herausforderungen stellt. Schmerzen beeinflussen die Hom\u00f6ostase des Menschen negativ. Compliance der Patientin und fundiertes Wissen \u00fcber Fetotoxizit\u00e4t und Teratogenit\u00e4t von Analgetika sind n\u00f6tig, um die Balance zwischen Therapie der Mutter und Sicherheit des Ungeborenen zu wahren.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ziel der Arbeit<\/jats:title>\n                <jats:p>ExpertInnen verschiedener Disziplinen, die mit der Betreuung von schwangeren Schmerzpatientinnen betraut sind, haben sich zusammengeschlossen, um medikament\u00f6se und nichtmedikament\u00f6se Therapiekonzepte zu erstellen, mit dem Ziel, eine suffiziente Analgesie von schwangeren Schmerzpatientinnen zu erm\u00f6glichen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material und Methode<\/jats:title>\n                <jats:p>Relevante Fragestellungen wurden durch ExpertInnen formuliert und einer Literatursuche unterzogen. Kombiniert mit weiteren nationalen und internationalen Empfehlungen wurden Behandlungskonzepte entwickelt, interdisziplin\u00e4r diskutiert und im Anschluss Kernaussagen erstellt, die mit Empfehlungsgraden abgestuft wurden.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ergebnisse<\/jats:title>\n                <jats:p>Abh\u00e4ngig vom Trimenon k\u00f6nnen bei Schmerzen Paracetamol, Ibuprofen, Diclofenac, Metamizol und Opioide wohl\u00fcberlegt verabreicht werden, besondere Vorsicht ist bei nichtsteroidalen Antirheumatika (NSAR) im letzten Trimenon geboten. COX-2-Hemmer werden nicht empfohlen. Bei neuropathischen Schmerzen gelten Amitriptylin, Duloxetin, Venlafaxin als sicher. Bei starker Migr\u00e4ne kann Sumatriptan zum Einsatz kommen. Nichtmedikament\u00f6se Therapien wie transkutane elektrische Nervenstimulation (TENS-Therapie), Kinesio-Tapes und Akupunktur gelten als sicher. Lymphdrainagen werden bei \u00d6demen empfohlen, sofern sie nicht durch eine Pr\u00e4eklampsie bedingt sind.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Schlussfolgerung<\/jats:title>\n                <jats:p>Die Therapie sollte mit einer nichtmedikament\u00f6sen Behandlung beginnen und eskalierend in einer Kombination aus medikament\u00f6sen und nichtmedikament\u00f6sen Konzepten enden.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00482-021-00571-4","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T08:02:52Z","timestamp":1627545772000},"page":"382-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Schmerztherapie in der Schwangerschaft","Pain management during pregnancy"],"prefix":"10.1007","volume":"35","author":[{"given":"Daniela","family":"Marhofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Jaksch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Aigm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Jochberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berndt","family":"Urlesberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Pils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Likar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Kayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roswitha","family":"Wallner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Gr\u00f6gl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"571_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2174\/138920012800166607","volume":"13","author":"R Antonucci","year":"2012","unstructured":"Antonucci\u00a0R, Zaffanello\u00a0M, Puxeddu\u00a0E et al (2012) Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn. Curr Drug Metab 13:474\u2013490","journal-title":"Curr Drug Metab"},{"key":"571_CR2","first-page":"1987","volume":"45","author":"CB Avella-Garcia","year":"2016","unstructured":"Avella-Garcia\u00a0CB, Julvez\u00a0J, Fortuny\u00a0J et al (2016) Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms. Int J Epidemiol 45:1987\u20131996","journal-title":"Int J Epidemiol"},{"key":"571_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1651-2227.2010.01942.x","volume":"100","author":"E Bakkeheim","year":"2011","unstructured":"Bakkeheim\u00a0E, Mowinckel\u00a0P, Carlsen\u00a0KH et\u00a0al (2011) Paracetamol in early infancy: the risk of childhood allergy and asthma. Acta Paediatr 100:90\u201396","journal-title":"Acta Paediatr"},{"key":"571_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ejogrb.2004.07.004","volume":"119","author":"B Bar-Oz","year":"2005","unstructured":"Bar-Oz\u00a0B, Clementi\u00a0M, Di Giantonio\u00a0E et al (2005) Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study. Eur J Obstet Gynecol Reprod Biol 119:176\u2013179","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"571_CR5","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(08)61445-2","volume":"372","author":"R Beasley","year":"2008","unstructured":"Beasley\u00a0R, Clayton\u00a0T, Crane\u00a0J et\u00a0al (2008) Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6\u20137\u00a0years: analysis from Phase Three of the ISAAC programme. Lancet 372:1039\u20131048","journal-title":"Lancet"},{"key":"571_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/acupmed-2017-011436","volume":"36","author":"TR Bergamo","year":"2018","unstructured":"Bergamo\u00a0TR, Latorraca\u00a0COC, Pachito\u00a0DV et al (2018) Findings and methodological quality of systematic reviews focusing on acupuncture for pregnancy-related acute conditions. Acupunct Med 36:146\u2013152","journal-title":"Acupunct Med"},{"issue":"8","key":"571_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/papr.12814","volume":"19","author":"RE Black","year":"2019","unstructured":"Black\u00a0RE, Khor\u00a0KE, Kennedy\u00a0D et\u00a0al (2019) Use and pain management in pregnangcy: a critical review. Pain Pract 19(8):875\u2013899","journal-title":"Pain Pract"},{"key":"571_CR8","unstructured":"https:\/\/www.embryotox.de. Zugegriffen: 1. Juni 2021"},{"key":"571_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/01.psy.0000170331.74960.ad","volume":"67","author":"ME Coussons-Read","year":"2005","unstructured":"Coussons-Read\u00a0ME, Okun\u00a0ML, Schmitt\u00a0MP et al (2005) Prenatal stress alters cytokine levels in a\u00a0manner that may endanger human pregnancy. Psychosom Med 67:625\u2013631","journal-title":"Psychosom Med"},{"key":"571_CR10","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1111\/j.1526-4610.2009.01529.x","volume":"49","author":"M Cunnington","year":"2009","unstructured":"Cunnington\u00a0M, Ephross\u00a0S, Churchill\u00a0P (2009) The safety of sumatriptan and naratriptan in pregnancy: what have we learned. Headache 49:1414\u20131422","journal-title":"Headache"},{"key":"571_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00404-008-0707-3","volume":"279","author":"T da Silva Dal Pizzol","year":"2009","unstructured":"da Silva Dal Pizzol\u00a0T, Sch\u00fcler-Faccini\u00a0L, Mengue\u00a0SS et al (2009) Dipyrone use during pregnancy and adverse perinatal events. Arch Gynecol Obstet 279:293\u2013297","journal-title":"Arch Gynecol Obstet"},{"key":"571_CR12","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/bcp.12653","volume":"80","author":"S Daniel","year":"2015","unstructured":"Daniel\u00a0S, Koren\u00a0G, Lunenfeld\u00a0E et\u00a0al (2015) NSAIDs and spontaneous abortions\u2014True effect or an indication bias. Br J Clin Pharmacol 80:750\u2013754","journal-title":"Br J Clin Pharmacol"},{"key":"571_CR13","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3899\/jrheum.120453","volume":"39","author":"S Daniel","year":"2012","unstructured":"Daniel\u00a0S, Matok\u00a0I, Gorodischer\u00a0R et\u00a0al (2012) Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy. J\u00a0Rheumatol 39:2163\u20132169","journal-title":"J Rheumatol"},{"key":"571_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/bjsports-2018-099400","volume":"53","author":"MH Davenport","year":"2019","unstructured":"Davenport\u00a0MH, Marchand\u00a0AA, Mottola\u00a0MF et al (2019) Exercise for the prevention and treatment of low back, pelvic girdle and lumbopelvic pain during pregnancy: a\u00a0systematic review and meta-analysis. Br J Sports Med 53:90\u201398","journal-title":"Br J Sports Med"},{"key":"571_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/AOG.0b013e3181c52616","volume":"115","author":"ML Feldkamp","year":"2010","unstructured":"Feldkamp\u00a0ML, Meyer\u00a0RE, Krikov\u00a0S et\u00a0al (2010) Acetaminophen use in pregnancy and risk of birth defects: findings from the national birth defects prevention study. Obstet Gynecol 115:109\u2013115","journal-title":"Obstet Gynecol"},{"key":"571_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00482-020-00472-y","volume":"34","author":"W Haeuser","year":"2020","unstructured":"Haeuser\u00a0W, Bock\u00a0F, Hueppe\u00a0M et\u00a0al (2020) Empfehlungen zur zweiten Aktualisierung der Leitlinie LONTS. Schmerz 34:204\u2013244","journal-title":"Schmerz"},{"key":"571_CR17","unstructured":"https:\/\/www.acog.org\/womens-health\/resources-for-you#f:topic=[During%20Pregnancy]&f:@patientportalcontenttype=[FAQs,FAQs%20for%20Teens]. Zugegriffen: 1. Juni 2021"},{"key":"571_CR18","unstructured":"https:\/\/www.oesg.at\/fuer-patienten\/patienteninformation\/index.html. Zugegriffen: 1. Juni 2021"},{"key":"571_CR19","unstructured":"https:\/\/www.schmerzgesellschaft.de\/topnavi\/patienteninformationen\/besonderheiten-bei-schmerz\/schmerztherapie-in-schwangerschaft-und-stillzeit. Zugegriffen: 1. Juni 2021"},{"key":"571_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00482-016-0167-9","volume":"30","author":"S Hultzsch","year":"2016","unstructured":"Hultzsch\u00a0S, Schaefer\u00a0C (2016) Analgesic drugs during pregnancy. Schmerz 30:583\u2013593","journal-title":"Schmerz"},{"key":"571_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00482-013-1382-2","volume":"28","author":"W Jaksch","year":"2014","unstructured":"Jaksch\u00a0W, Messerer\u00a0B, Baumgart\u00a0H et\u00a0al (2014) Austrian interdisciplinary recommendations on pediatric perioperative pain management: background, aims, methods and key messages. Schmerz 28:7\u201313","journal-title":"Schmerz"},{"key":"571_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2165\/11590370-000000000-00000","volume":"34","author":"B K\u00e4ll\u00e9n","year":"2011","unstructured":"K\u00e4ll\u00e9n\u00a0B, Nilsson\u00a0E, Otterblad Olausson\u00a0P (2011) Delivery outcome after maternal use of drugs for migraine: a\u00a0register study in Sweden. Drug Saf 34:691\u2013703","journal-title":"Drug Saf"},{"key":"571_CR23","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1542\/peds.2013-3524","volume":"134","author":"P Kocherlakota","year":"2014","unstructured":"Kocherlakota\u00a0P (2014) Neonatal abstinence syndrome. Pediatrics 134:e547\u2013e561","journal-title":"Pediatrics"},{"key":"571_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/bcpt.12497","volume":"118","author":"D Lassen","year":"2015","unstructured":"Lassen\u00a0D, Ennis\u00a0ZN, Damkier\u00a0P (2015) First-trimester pregnancy exposure to venlafaxine or duloxetine and risk of major congenital malformations: a systematic review. Basic Clin Pharmacol Toxicol 118:32\u201336","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"571_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/head.12500","volume":"55","author":"A Marchenko","year":"2015","unstructured":"Marchenko\u00a0A, Etwel\u00a0F, Olutunfese\u00a0O et al (2015) Pregnancy outcome following prenatal exposure to triptan medications: a\u00a0meta-analysis. Headache 55:490\u2013501","journal-title":"Headache"},{"key":"571_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1526-4610.2010.01619.x","volume":"50","author":"K Nezvalov\u00e1-Henriksen","year":"2010","unstructured":"Nezvalov\u00e1-Henriksen\u00a0K, Spigset\u00a0O, Nordeng\u00a0H (2010) Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. Headache 50:563\u2013575","journal-title":"Headache"},{"key":"571_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-0036-1593933","volume":"26","author":"M Quittan","year":"2016","unstructured":"Quittan\u00a0M, Bily\u00a0W, Crevenna\u00a0R et al (2016) Transcutaneous Electrical Nerve Stimulation (TENS) in patients with pregnancy-induced low back pain and\/or pelvic girdle pain. Phys Med Rehab Kuror 26:91\u201395","journal-title":"Phys Med Rehab Kuror"},{"key":"571_CR28","first-page":"54","volume-title":"Arzneimittel in der Schwangerschaft und Stillzeit","author":"C Schaefer","year":"2011","unstructured":"Schaefer\u00a0C, Spielmann\u00a0H, Vetter\u00a0K, Weber-Sch\u00f6ndorfer\u00a0C (2011) Arzneimittel in der Schwangerschaft und Stillzeit, 8.\u00a0Aufl. Urban & Fischer, M\u00fcnchen, S 54\u201356","edition":"8"},{"key":"571_CR29","first-page":"267","volume-title":"Arzneimittel in der Schwangerschaft und Stillzeit","author":"C Schaefer","year":"2011","unstructured":"Schaefer\u00a0C, Spielmann\u00a0H, Vetter\u00a0K, Weber-Sch\u00f6ndorfer\u00a0C (2011) Arzneimittel in der Schwangerschaft und Stillzeit, 8.\u00a0Aufl. Urban & Fischer, M\u00fcnchen, S 267","edition":"8"},{"key":"571_CR30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1067\/mob.2002.125281","volume":"187","author":"CS Stika","year":"2002","unstructured":"Stika\u00a0CS, Gross\u00a0GA, Leguizamon\u00a0G et\u00a0al (2002) A prospective randomized safety trial of celecoxib for treatment of preterm labor. Am J Obstet Gynecol 187:653\u2013660","journal-title":"Am J Obstet Gynecol"},{"key":"571_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/00002508-200305000-00002","volume":"19","author":"MJ Wunsch","year":"2003","unstructured":"Wunsch\u00a0MJ, Stanard\u00a0V, Schnoll\u00a0SH (2003) Treatment of pain in pregnancy. Clin J Pain 19:148\u2013155","journal-title":"Clin J Pain"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-021-00571-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-021-00571-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-021-00571-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T10:06:10Z","timestamp":1637748370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-021-00571-4"}},"subtitle":["Eine expertInnenbasierte interdisziplin\u00e4re Konsensus-Empfehlung","An expert-based interdisciplinary consensus recommendation"],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["571"],"URL":"https:\/\/doi.org\/10.1007\/s00482-021-00571-4","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,29]]},"assertion":[{"value":"17 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.\u00a0Marhofer, W.\u00a0Jaksch, T.\u00a0Aigm\u00fcller, S.\u00a0Jochberger, K.\u00a0Pils, B.\u00a0Maier, R.\u00a0Likar, B.\u00a0Kayer, R.\u00a0Wallner und P.\u00a0Fink und geben an, dass kein Interessenkonflikt besteht. G.\u00a0Gr\u00f6gl f\u00fchrt Beratungs- und Vortragst\u00e4tigkeit f\u00fcr folgende Firmen aus: Sanofi und Bionorica, weiters besteht eine Vortragst\u00e4tigkeit f\u00fcr folgende Firmen: Ratiopharm, Munidpharma und Genericon. B.\u00a0Urlesberger war 2019 Mitglied des Advisory Boards der Firma Milupa\/Danone und erh\u00e4lt Vortragshonorare von folgenden Firmen: Medtronic und Masimo.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}